SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is facing intense downward pressure driven by a mix of broader SaaS sector volatility and aggressive short-selling as investors debate the impact of AI competition on its long-term moat. While the community remains deeply divided between those viewing the current price as a deep-value buying opportunity and those fearing further dilution from upcoming lockup expirations and insider sales.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as a veteran parody project that has evolved from a 2011 BitcoinTalk forum joke into an on-chain meme asset on Solana. The community is actively debating its potential as the original meme coin, drawing comparisons to Bitcoin while leveraging its long-standing lore to attract holders who are positioning for a speculative long-term breakout.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is currently at the center of a heated debate over whether AI disruption via tools like Anthropic represents a fatal structural threat to legacy SaaS providers or a temporary, sentiment-driven repricing opportunity. Community members remain deeply divided between short-sellers anticipating a permanent valuation collapse and bulls who argue that major software incumbents are oversold and fundamentally resilient, leading to high-volume institutional buying and significant volatility.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently at the center of a heated debate between retail traders who view it as an unstoppable "money machine" fueled by insatiable AI infrastructure demand and skeptics pointing to extreme valuation premiums and potential technical divergences. While bullish participants highlight the sector's leadership role and resilient price action, a vocal cohort of bears remains focused on the potential for a sharp correction as they monitor key support levels and signs of overextension.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as investors digest the recent $100 million upsized financing and look ahead to major milestones, including the completion of NEXICART-2 enrollment and a pending BLA submission. The community is actively debating the company's valuation, institutional accumulation by major funds, and the potential for a strategic partnership or buyout given the strength of NXC-201's clinical data.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management systems, as well as other tools, integrations, and native payment solutions. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is facing intense selling pressure as investors grapple with concerns that generative AI and agentic platforms could disrupt traditional SaaS business models and drive down demand for seat-based licensing. While many analysts maintain buy ratings and emphasize the company's strong fundamentals, the stock is struggling to find a bottom as the market remains skeptical about the long-term impact of AI on the software sector's growth potential.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing significant momentum driven by massive whale accumulation, liquidation of short positions, and speculative anticipation of major corporate partnerships. While bulls are focused on the token's potential within its decentralized event ecosystem, the community remains divided between those expecting further breakout rallies and skeptics warning of a potential correction due to incoming supply releases.

Maulcoin

Maulcoin is trending as its community aggressively rallies to regain market momentum and push the ticker back onto major trading platforms. Supporters are actively engaging in social media raids and liquidity-focused community building to drive visibility for what they describe as a long-term, anti-rug project.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing heightened volatility and intense community debate following an unexpected endorsement from President Trump, which has fueled a battle between retail bulls and short-sellers like Michael Burry. Traders are closely monitoring the stock's ability to hold critical support levels while reacting to concerns over potential competition from AI startups and the broader impact of political influence on market sentiment.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending as investors monitor the bank's involvement in the recent Epstein file disclosures and navigate volatility alongside broader sector concerns regarding private credit exposure and software stock performance. While some analysts maintain a bullish outlook citing resilient investment banking and AI infrastructure pushes, community sentiment remains mixed, with active debate over potential downside risks and institutional positioning in banking names.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hennion & Walsh Asset Management Inc. Has $3.37 Million Holdings in ProKidney Corp. $PROK

Hennion & Walsh Asset Management Inc. lifted its stake in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 63.5% in the 4th quarter, according to its most recent Form 13F filing with the...

ProKidney (NASDAQ:PROK) Shares Up 5.9%  - Here's Why

ProKidney (NASDAQ:PROK) Trading 5.9% Higher - What's Next...

ProKidney (NASDAQ:PROK) Trading Down 7.6% - Here's What Happened

ProKidney (NASDAQ:PROK) Stock Price Down 7.6% - Should You Sell...

Q2 Earnings Forecast for ProKidney Issued By HC Wainwright

ProKidney Corp. (NASDAQ:PROK - Free Report) - Stock analysts at HC Wainwright issued their Q2 2026 earnings per share (EPS) estimates for shares of ProKidney in a research note issued on Thursday, March 19th. HC Wainwright analyst J. Pantginis expects that the company will post earnings per share of...

ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of ProKidney Corp. (NASDAQ:PROK - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat reports. Two...

ProKidney (NASDAQ:PROK) Cut to Sell at Wall Street Zen

Wall Street Zen cut ProKidney from a "hold" rating to a "sell" rating in a research note on Saturday...

Equities Analysts Set Expectations for ProKidney Q1 Earnings

ProKidney Corp. (NASDAQ:PROK - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for ProKidney in a research report issued on Thursday, March 19th. HC Wainwright analyst J. Pantginis forecasts that the company will post earnings of ($0.12) per share f...

ProKidney (NASDAQ:PROK) Raised to "Strong-Buy" at Jefferies Financial Group

Jefferies Financial Group upgraded shares of ProKidney to a "strong-buy" rating in a research note on Wednesday...

ProKidney (NASDAQ:PROK) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

ProKidney (NASDAQ:PROK - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.16) by...

ProKidney (NASDAQ:PROK) Stock Price Down 4.7% - Time to Sell?

ProKidney (NASDAQ:PROK) Shares Down 4.7% - What's Next...

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

Current Price	$1.95
Prev Close	$1.90
Open	$1.93
Dividend Yield	0.00%
50-Day Moving Average	$2.04
Beta	2.56
Avg. Volume	785,190.62
PE Ratio	-3.78

52-Week High	$7.13
52-Week Low	$0.54
Market Capitalization	$573.64M
EPS (Annual)	-$0.515
Price to Book	-0.27
Revenue Per Employee	$3,865.80

PROK
ProKidney Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PROK News

PROKProKidney Corp